Semaglutide improves heart health outcomes beyond weight loss: ESC 2024 Dr. Kamal Kant Kohli12 Sept 2024 8:15 PM ISTSemaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss,...
Single measures of non HDL-C and LDL-C between ages 18 and 30 years may predic CAD, finds study Medha Baranwal11 Sept 2024 9:00 AM ISTUSA: Single measurements of non-HDL cholesterol (non-HDL-C) and LDL cholesterol (LDL-C) taken between 18 and 30 years of age are strong indicators of...
Olpasiran Shows Prolonged Lipoprotein(a) Reduction: Nearly 50% Drop Maintained for Up to Year After Treatment, Study Medha Baranwal9 Sept 2024 9:48 AM ISTUSA: In a recent follow-up study of the OCEAN(a)-DOSE clinical trial, new data has revealed the extended benefits of Olpasiran, a promising siRNA...
Early Adult LDL-C and Non-HDL-C Levels Strongly Predict Later ASCVD Risk, suggests study Dr Riya Dave6 Sept 2024 8:30 AM ISTResearchers found that a single measurement of low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (non-HDL-C), if...
Weight loss drug semaglutide reduced COVID-19 related deaths during pandemic, finds study Dr. Kamal Kant Kohli4 Sept 2024 6:15 AM ISTPatients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an...
Wearable heart monitor increases diagnosis of irregular heart rhythm: ESC 2024 Dr. Kamal Kant Kohli3 Sept 2024 6:30 AM ISTWearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a...
Olpasiran effective therapeutic option for lowering lipoprotein(a) levels, suggests study Jacinthlyn Sylvia30 Aug 2024 8:00 AM ISTA new study published in the Journal of the American College of Cardiology found that strong siRNA that lowers lipoprotein(a) (Lp(a)) over an extended...
Bariatric Surgery cuts risk of CVD and mortality among obese patients with sleep apnea: Study Dr. Kamal Kant Kohli16 Aug 2024 8:00 PM ISTA Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated...
Semaglutide Promotes Weight Loss and Improves HF Outcomes in Patients with Obesity-Related HFpEF: JACC Medha Baranwal8 Aug 2024 10:00 AM ISTUSA: Insights from the STEP-HFpEF program showed the efficacy of semaglutide in reducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) in...
Liraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD: Study Dr. Shravani Dali5 Aug 2024 9:00 AM ISTLiraglutide improves myocardial perfusion, myocardial energetics and exercise capacity in Diabetics without CVD suggests a study published in the...
New Wearable Defibrillator Highly Successful in Preventing Sudden Cardiac Arrest with Excellent Patient Adherence: Study Medha Baranwal1 Aug 2024 9:45 AM ISTUSA: A Jewel patch-wearable cardioverter-defibrillator effectively administered life-saving shocks to prevent sudden cardiac arrest (SCA), and users...
Predicting PCI Benefits in cath lab: Study Validates Symptom Verification with Ischemic Stimulus Medha Baranwal24 July 2024 9:30 AM ISTUK: ORBITA-STAR, an n-of-1 study, showed that verifying patient symptoms with an ischemic stimulus on the cath lab table can help predict which stable...
